CompletedPhase 1NCT04773431
Safety Evaluation of LSCD101 Transplantation for Limbal Stem Cell Deficiency
Studying Limbal stem cell deficiency
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- CliPS Co., Ltd
- Principal Investigator
- SoHyang Chung, MD,Ph.DThe Catholic University of Korea
- Intervention
- LSCD101 (Cultured Autologous Limbal Epithelial Cell Sheet) transplantation(drug)
- Enrollment
- 6 target
- Eligibility
- 19 years · All sexes
- Timeline
- 2020 – 2021
Study locations (1)
- CliPS, Seoul, South Korea
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT04773431 on ClinicalTrials.govOther trials for Limbal stem cell deficiency
Additional recruiting or active studies for the same condition.
- RECRUITINGNCT07119580Association Between Limbal Function and Tear Proteomics in Chronic Ocular Diseases: Focusing on GlaucomaNational Taiwan University Hospital
- RECRUITINGNANCT06265298Implementation of a Protocol for the Transdifferentiation of Buccal Mucosal Epithelium Into Corneal EpitheliumUniversity Hospital, Montpellier
- RECRUITINGPHASE1NCT06452316Study to Evaluate the Safety and Efficacy of CSB-001 Ophthalmic Solution 0.1% in Subjects With Limbal Stem Cell DeficiencyClaris Biotherapeutics, Inc.
- RECRUITINGNANCT04995926Labial Mucosal Epithelium Grafting for Corneal Limbus SubstitutionThe S.N. Fyodorov Eye Microsurgery State Institution
- RECRUITINGPHASE1, PHASE2NCT03949881Cultured Autologous Oral Mucosa Epithelial Sheet for the Treatment of Bilateral Limbal Stem Cell DeficiencyHospices Civils de Lyon
- ACTIVE NOT RECRUITINGPHASE1NCT03957954Stem Cell Therapy for Limbal Stem Cell DeficiencyUniversity of California, Los Angeles
- RECRUITINGNCT02886611Limbal Stem Cell Deficiency of Genetic Origin: Genotype-phenotype CorrelationFondation Ophtalmologique Adolphe de Rothschild
- RECRUITINGNANCT01756365Autologous Cultured Corneal Epithelium (CECA) for the Treatment of Limbal Stem Cell DeficiencyCHU de Quebec-Universite Laval